Goal! Scientists have studied players in the FC Barcelona women’s teamEric Alonso/Getty Images The idea that we should make lifestyle adjustments depending on where we are in our menstrual cycle...

Postpartum use of domperidone to increase milk production in breastfeeding is not correlated with increased mental health-related emergency department visits. Medscape Medical News Source link : https://www.medscape.com/viewarticle/domperidone-safety-postpartum-mental-health-findings-2025a1000z7k?src=rss Author : Publish...

The combination of gastric electrical stimulation and pyloroplasty produces better outcomes than pyloroplasty alone in patients with refractory gastroparesis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/pyloroplasty-gastric-electric-stimulation-treats-2025a1000z7j?src=rss Author : Publish date...

Simi Jolaoso,Jack GoodmanandSarah Buckley,BBC Eye InvestigationsChance LetikvaWarning: Disturbing contentA little boy faces the camera. He is pale and has no hair."I am seven years old and I have cancer," he...

(MedPage Today) -- Six midlife symptoms of depression were tied to an increased risk of dementia, prospective research from the Whitehall II cohort showed. Depressive symptoms that emerged as midlife...

(MedPage Today) -- Decades-old fears of heart risks from eating saturated fats appeared to have been overblown for many individuals, according to a meta-analysis of randomized trials. Across 17 studies,...

(MedPage Today) -- The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced...

(MedPage Today) -- An aspiring neurosurgeon and a student leader of Brown University's campus Republicans were in a study group preparing for an economics final, with the end of the...

(MedPage Today) -- A smartphone-delivered digital cognitive behavioral therapy (CBT) intervention improved generalized anxiety disorder symptoms in adults, a randomized trial showed. Among 351 participants, 71% who engaged in a...

(MedPage Today) -- After finding abnormalities on low-dose CT lung cancer screening, many patients don't get the recommended level of follow-up care, a Medicare-linked registry analysis showed. Only 59.7% of...

(MedPage Today) -- The FDA approved trastuzumab deruxtecan (T-DXd; Enhertu) in combination with pertuzumab (Perjeta) for the first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer. Approval was...

(MedPage Today) -- The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin...

(MedPage Today) -- While most cannabis retailers recommended women not use blunts or tobacco while pregnant, about one in five suggested prenatal cannabis use was safe, according to a cross-sectional...

(MedPage Today) -- Rates of postpartum hemorrhage and severe postpartum hemorrhage were markedly higher with the use of objective blood loss assessment methods, suggesting that subjective assessment methods may be...

(MedPage Today) -- The scientifically unsound "Make America Healthy Again" (MAHA) initiative is devastating our country's scientific infrastructure, medical research capacity, epidemiologic surveillance, and public health response capacity. MAHA... Source...

(MedPage Today) -- Editor's Note: This will be David Nash's final "Focus on Policy" column for MedPage Today. Nash has been a pioneer in the field of population health, pushing...

(MedPage Today) -- Under a program designed to accelerate the approval of products that could address key national priorities, the FDA awarded a national priority voucher to teclistamab (Tecvayli) in...

(MedPage Today) -- The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC), the agency announced on Friday. The once-daily,...

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-first-class-drug-generalized-myasthenia-gravis-2025a1000z6f?src=rss Author : Publish...

(MedPage Today) -- The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium channel blocker is indicated......